Related Experiment Videos
Interleukin-1alpha production in human corneal scars
Iva Dekaris1, Nikica Gabrić, Damir Bosnar
1University Department of Ophthalmology, Lions Croatian Eye Bank, General Hospital, Holy Spirit, Zagreb, Croatia. i.dekaris@eeba.net
Collegium Antropologicum
|October 1, 2005
Summary
Interleukin-1 alpha (IL-1alpha) levels are elevated in corneal scars, particularly with early-stage neovascularization. This suggests IL-1alpha promotes blood vessel growth in scars, though graft rejection risk increases with vascularization regardless of IL-1alpha levels.
Area of Science:
- Ophthalmology
- Immunology
- Regenerative Medicine
Background:
- Corneal scars can impair vision and are often associated with neovascularization.
- Interleukin-1 alpha (IL-1alpha) is a pro-inflammatory cytokine implicated in tissue repair and angiogenesis.
Purpose of the Study:
- To investigate the correlation between IL-1alpha levels and neovascularization in corneal scars.
- To determine the relationship between IL-1alpha, vascularization, and graft rejection rates.
Main Methods:
- IL-1alpha levels were measured using immunoassay in corneal scar tissues from 27 patients undergoing corneal grafting.
- Patients were grouped based on the degree of corneal neovascularization (0 to IV/IV quadrants).
- Graft rejection rates were calculated for each vascularization group.
Main Results:
- Mean IL-1alpha concentration was significantly higher in corneal scars (6 ± 3.93 pg/mm3) compared to controls (1.25 ± 2.03 pg/mm3).
- IL-1alpha levels correlated with the extent of vascularization, except in highly vascularized scars (IV/IV).
- Graft rejection rates increased with higher degrees of corneal vascularization, irrespective of IL-1alpha levels.
Conclusions:
- Elevated IL-1alpha in corneal scars suggests its role in promoting early-stage neovascularization.
- While IL-1alpha is linked to vascular growth, high vascularization itself is the primary driver of increased corneal graft rejection risk.